Faculty Profiles - SHINDO Yuichiro

Papers - SHINDO Yuichiro

Division display 21 - 40 of about 123 ／ All the affair displays >>

気管支拡張症における慢性感染の意義：その評価と治療 Invited

進藤有一郎

呼吸器内科 Vol. 43 ( 4 ) page： 382 - 386 2023.4

Identification of two specific transcriptomic clusters of COVID-19 acute respiratory distress syndrome patients with different immune profiles and different outcomes.

Shindo Y, Dela Cruz CS, Witzenrath M

The European respiratory journal Vol. 61 ( 1 ) 2023.1

Predicting oxygen requirements in patients with coronavirus disease 2019 using an artificial intelligence-clinician model based on local non-image data Reviewed

Muto R, Fukuta S, Watanabe T, Shindo Y, Kanemitsu Y, Kajikawa S, Yonezawa T, Inoue T, Ichihashi T, Shiratori Y, Maruyama S

Front Med Vol. 9 page： 1042067 2022.11

Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens. Reviewed International journal

Kobayashi H, Shindo Y, Kobayashi D, Sakakibara T, Murakami Y, Yagi M, Matsuura A, Sato K, Matsui K, Emoto R, Yagi T, Saka H, Matsui S, Hasegawa Y, Central Japan Lung Study Group

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Vol. 124 page： 124 - 132 2022.11

Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia. Reviewed

Murakami Y, Shindo Y, Sano M, Okumura J, Kobayashi H, Sakakibara T, Iguchi M, Takahashi K, Yagi T, Matsui S, Hasegawa Y

Scientific reports Vol. 12 ( 1 ) page： 14564 2022.8

Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.

Sano M, Shindo Y, Takahashi K, Okumura J, Sakakibara T, Murakami Y, Iguchi M, Yagi T, Matsui S, Hasegawa Y

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 28 ( 6 ) page： 745 - 752 2022.6

コロナ第七波に向けて　求められる医療体制とは Invited Reviewed

進藤有一郎

Medical Tribune Vol. 55 ( 11 ) page： 3 2022.5

Broad-Spectrum Antibiotics and Mortality in Community-Acquired Pneumonia Patients with Low-Risk for Drug-Resistant Pathogens

Kobayasi H., Shindo Y., Kobayashi D., Sakakibara T., Murakami Y., Yagi M., Matsuura A., Sato K., Goto Y., Matsui S., Yagi T., Saka H., Hasegawa Y.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 205 2022.5

Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia.

Thabet N, Shindo Y, Okumura J, Sano M, Sakakibara T, Murakami Y, Kobayashi H, Saka H, Kondo M, Hasegawa Y, Central Japan Lung Study Group

Nagoya journal of medical science Vol. 84 ( 2 ) page： 247 - 259 2022.5

Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19.

Omote N, Kanemitsu Y, Inoue T, Yonezawa T, Ichihashi T, Shindo Y, Sakamoto K, Ando A, Suzuki A, Niimi A, Ito S, Imaizumi K, Hashimoto N

Internal medicine (Tokyo, Japan) Vol. 61 ( 2 ) page： 233 - 236 2022.1

A prediction rule for severe adverse events in all inpatients with community-acquired pneumonia: a multicenter observational study.

Sakakibara T, Shindo Y, Kobayashi D, Sano M, Okumura J, Murakami Y, Takahashi K, Matsui S, Yagi T, Saka H, Hasegawa Y

BMC pulmonary medicine Vol. 22 ( 1 ) page： 34 2022.1

Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection.

Nasrin S, Hegerle N, Sen S, Nkeze J, Sen S, Permala-Booth J, Choi M, Sinclair J, Tapia MD, Johnson JK, Sow SO, Thaden JT, Fowler VG Jr, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM

BMC microbiology Vol. 22 ( 1 ) page： 13 2022.1

COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.

Goto Y, Sakamoto K, Fukihara J, Suzuki A, Omote N, Ando A, Shindo Y, Hashimoto N

Frontiers in medicine Vol. 9 page： 815924 2022

Predicting oxygen requirements in patients with coronavirus disease 2019 using an artificial intelligence-clinician model based on local non-image data.

Muto R, Fukuta S, Watanabe T, Shindo Y, Kanemitsu Y, Kajikawa S, Yonezawa T, Inoue T, Ichihashi T, Shiratori Y, Maruyama S

Frontiers in medicine Vol. 9 page： 1042067 2022

The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.

Kasugai D, Jingushi N, Omote N, Shindo Y, Goto Y

American journal of respiratory and critical care medicine Vol. 204 ( 12 ) page： 1489 - 1489 2021.12

COVID-19の薬物療法のイロイロ Invited Reviewed

進藤有一郎

みんなの呼吸器Respica Vol. 19 ( 6 ) page： 20 - 27 2021.12

Understanding the Host in the Management of Pneumonia An Official American Thoracic Society Workshop Report Reviewed International coauthorship

Dela Cruz, CS; Evans, SE; Restrepo, MI; Dean, N; Torres, A; Amara-Elori, I; Awasthi, S; Caler, E; Cao, B; Chalmers, JD; Chastre, J; Cohen, TS; Cohen, AH; Crothers, K; Di, YP; Egan, ME; Feldman, C; Gautam, S; Halstead, ES; Herold, S; Jones, BE; Luna, C; Niederman, MS; Mendez, R; Menendez, R; Mizgerd, JP; Nusrat, R; Ramirez, J; Shindo, Y; Stevens, C; Waterer, G; Yeligar, SM; Wunderink, RG

ANNALS OF THE AMERICAN THORACIC SOCIETY Vol. 18 ( 7 ) page： 1087 - 1097 2021.7

市中肺炎のマネージメント Invited

進藤有一郎

呼吸器内科 Vol. 39 ( 6 ) page： 465 - 470 2021.6

Usefulness of Respiratory Mechanics and Laboratory Parameter Trends as Markers of Early Treatment Success in Mechanically Ventilated Severe Coronavirus Disease: A Single-Center Pilot Study.

Kasugai D, Ozaki M, Nishida K, Hiraiwa H, Jingushi N, Numaguchi A, Omote N, Shindo Y, Goto Y

Journal of clinical medicine Vol. 10 ( 11 ) 2021.6

教えて！○○科のお医者さん　呼吸器内科 Invited

進藤有一郎

ニュートン別冊 page： 74 - 77 2021.6

　 PREV - NEXT 　

<SHINDO Yuichiro>

Papers - SHINDO Yuichiro